Similarly, VEGF-C and VEGF-D expression have been correlated with clinical outcomes in GBC, with GBC patients reporting a higher incidence of lymph node metastasis, and thus suggesting a putative role for VEGF-C and -D in promoting tumor progression [62]. The gene discussed is VEGFC; the disease is neoplasm.